DR Mark Dowling
Honorary Conjoint Senior Fellow
The Sir Peter MacCallum Department of Oncology
94 Scholarly works
4 Projects
HIGHLIGHTS
2026
Journal article
Richter transformation: emerging immunologic strategies beyond chemoimmunotherapy.
DOI: 10.1182/bloodadvances.20260201972026
Journal article
Shortened axi-cel manufacturing drives rapid in vivo expansion and shifts the acute toxicity profile in R/R LBCL.
DOI: 10.1182/bloodadvances.20260216182026
Journal article
Pre-transplant azacitidine does not improve survival in allogeneic HSCT for higher-risk MDS
DOI: 10.1038/s41409-026-02874-52026
Journal article
Persistent and pathogen-specific infection risk during long-term survivorship after CD19 CAR-T: An Australian multi-centre cohort study.
DOI: 10.1016/j.cmi.2026.06.0192026
Research grants (ARC, NHMRC, MRFF)
Next Generation Cellular Immunotherapy for Multiple Myeloma and Beyond
2025
Research grants (other domestic)
Clinical, Laboratory and Radiological Predictive Factors for Safety and Efficacy of Chimeric Antigen Receptor (CAR) T-Cell Therapy in Australia: A Multi-Centre Real-World Study
2022
Research grants (other domestic)
Adjuvant Immunotherapy to Improve the Efficacy, Durability, and Cost Effectiveness of CAR T-Cell Therapy for Aggressive Lymphoma
RECENT SCHOLARLY WORKS
2026
Journal article
Infections in the First 30 Days after Chimeric Antigen Receptor T-Cell Therapy in Patients Not Receiving Fluoroquinolone Prophylaxis.
DOI: 10.1016/j.jtct.2026.03.0402026
Journal article
Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma
DOI: 10.1182/blood.20250323072026
Journal article
DEVELOPMENT AND CLINICAL DELIVERY OF AN AUSTRALIAN-MANUFACTURED CD19 CAR-T CELL THERAPY: THE PLATYPS STUDY
DOI: 10.1016/j.jcyt.2026.1026472026
Journal article
Clinical outcomes with venetoclax-based therapy in patients with relapsed/refractory B-cell lymphomas
DOI: 10.1080/10428194.2025.25797212026
Journal article
Neurological implications of chimeric antigen receptor-T cell therapy
DOI: 10.1136/bmjno-2025-0014912026
Journal article
A Critical Review of Clinical Factors and Tools for Predicting Chimeric Antigen Receptor T-Cell Toxicities
DOI: 10.1016/j.jtct.2026.05.027
RECENT PROJECTS
2026
Research grants (other domestic)
Development of a Novel Nanobody-Secreting CAR-T Cell for the Treatment of Multiple Myeloma